Determining Criticality—Process Parameters and Quality Attributes Part III: Process Control Strategies—Criticality throughout the Lifecycle.
| Publicado en: | BioPharm International Vol. 27; no. 3; pp. 26 - 36 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Mar2014
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103985167&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 103985167 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Mar2014 vid: 27 iid: 3 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 103985167 2012674857 103985167 ppf: 26 ppct: 10 formats: fmt: @attributes: type: P tig: atl: Determining Criticality—Process Parameters and Quality Attributes Part III: Process Control Strategies—Criticality throughout the Lifecycle. aug: au: Mitchell, Mark affil: Principal engineer, Pharmatech Associates sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|